Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
October, 2026
October 2026
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Augustina Isioma Ikusemoro: A Small Antigen with Big Clinical Consequences
Augustina Isioma Ikusemoro/LinkedIn
Apr 2, 2026, 04:47

Augustina Isioma Ikusemoro: A Small Antigen with Big Clinical Consequences

Augustina Isioma Ikusemoro, Hematology and Transfusion Medicine Specialist at Sharjah Blood Transfusion and Research Center, shared a post on LinkedIn:

“Know Your Kell: A Small Antigen with Big Clinical Consequences

The Kell antigen system is one of the most clinically significant blood group systems after ABO and Rh, yet it is often under-recognized outside specialist transfusion practice.

This infographic highlights why the K antigen (K1) matters in everyday transfusion medicine:

  • The Kell antigen is expressed on red blood cells and can trigger clinically significant alloimmunization
  • Anti-K antibodies are a major cause of Hemolytic Disease of the Fetus and Newborn (HDFN)
  • Sensitization commonly occurs after transfusion or pregnancy
  • Anti-K is typically IgG reactive at 37°C, capable of crossing the placenta
  • Safe transfusion practice requires Kell-negative blood for patients with anti-K antibodies

Understanding Kell compatibility is essential for protecting:

  • chronically transfused patients
  • women of child-bearing age
  • fetuses at risk of HDFN
  • patients with previous alloimmunization

Because in transfusion medicine, compatibility goes far beyond ABO and RhD.

Blood Doki — Advancing transfusion safety through education, advocacy, and clinical awareness.”

Augustina Isioma Ikusemoro: A Small Antigen with Big Clinical Consequences

Stay updated with Hemostasis Today.

ABO Augustina Isioma Ikusemoro HDFN Health Hematology Hemostasis News Hemostasis Today Kell antigen Medicine Rh Transfusion Medicine
NewsFeed